Please wait a minute...
图/表 详细信息
医院获得性细菌性脑膜炎患者预后不良的危险因素分析及列线图预测模型的构建
杨梅, 廖啟安, 谭全会, 李婷婷, 张毅, 陈洁, 汤正好
诊断学理论与实践    2025, 24 (04): 441-448.   DOI:10.16150/j.1671-2870.2025.04.011
摘要   (27 HTML2 PDF(pc) (719KB)(4)  

目的:探讨医院获得性细菌性脑膜炎(hospital-acquired bacterial meningitis, HABM)患者预后不良的危险因素,并构建预测其发生的列线图模型。方法:连续纳入上海交通大学医学院附属第六人民医院2013年1月至2020年12月收治的110例医院获得性细菌性脑膜炎患者,根据出院时是否死亡将其分为死亡组(n=22)和生存组(n=88),同时随机将110例患者分为建模组(n=77)和验证组(n=33)。应用最小绝对收缩和选择算子(least absolute shrinkage and selection operator,LASSO)回归及多因素Logistic回归筛选HABM患者预后不良的危险因素,并基于危险因素构建列线图模型,采用受试者操作特征(receiver operating characteristic curve,ROC)曲线的曲线下面积(area under curve,AUC)评估模型区分度,用校准曲线评估模型内部一致性情况。结果:基于LASSO回归共筛选出脑脊液(cerebro-spinal fluid,CSF)微生物培养革兰染色阳性、血常规中性粒细胞计数升高、降钙素原升高、CSF蛋白含量升高、凝血酶原时间缩短、血培养阳性、腰池引流史这7个因素,建立了HABM预后不良列线图预测模型,建模组及验证组ROC曲线的AUC分别为0.931、0.862,校准图显示校准曲线与理想曲线吻合较好,具有良好的拟合优度。结论:本研究构建危险因素列线图模型对住院HABM患者死亡具有较好的预测性、一致性和临床实用性,有助于临床医生对HABM患者预后不良的发生风险进行初步评估。


Characteristics Death group
(n=22)
Survival group
(n=88)
P-value Characteristics Death group
(n=22)
Survival group
(n=88)
P value
Age(years) 61 ± 11 55 ± 13 0.057 Antithrombin Ⅲ activity(%) 65 ± 25 89 ± 16 <0.001
Sex(%) 0.483 More than two surgeries(%) 0.212
Female 9 (40.9%) 29 (33.0%) No 13 (59.1%) 64 (72.7%)
Male 13 (59.1%) 59 (67.0%) Yes 9 (40.9%) 24 (27.3%)
Admission GCS 7.9 ± 4.0 9.3 ± 3.7 0.073 blood culture(%)) 0.001
Gram stain of CSF microbial[n(%)] 0.01 No 11 (50.0%) 73 (83.0%)
Negetive 13 (59.1%) 26 (29.5%) Yes 11 (50.0%) 15 (17.0%)
Positive 9 (40.9%) 62 (70.5%) GCS on the day of culture 7.5 ± 3.3 9.4 ± 3.5 0.018
CSF Chloride(mmol/L) 120 ± 17 119 ± 16 0.988 Surgical incision length greater than 10 cm(%) 0.19
CSF Sugar(mmol/L) 2.26 ± 2.13 3.50 ± 2.14 0.02 No 12 (54.5%) 61 (69.3%)
CSF protein(mmol/L) 5.6 ± 5.3 4.2 ± 12.8 0.023 Yes 10 (45.5%) 27 (30.7%)
CSF WBC>10(× 106/L) 0.273 Surgical time greater than 4 h(%) 0.529
<100 12 (54.5%) 59 (67.0%) No 17 (77.3%) 74 (84.1%)
>100 10 (45.5%) 29 (33.0%) Yes 5 (22.7%) 14 (15.9%)
CSF RBC[n(%)] 0.775 Tracheal intubation/incision greater than 7 days(%) 0.021
Little 11 (50.0%) 47 (53.4%) No 3 (13.6%) 35 (39.8%)
Many 11 (50.0%) 41 (46.6%) Yes 19 (86.4%) 53 (60.2%)
WBC(× 109/L) 14.7 ± 7.2 11.7 ± 5.9 0.07 Fever(%) 0.306
Neutrophil(× 109/L) 12.7 ± 6.7 10.6 ± 15.1 0.037 No 5 (22.7%) 30 (34.1%)
RBC(× 1012/L) 3.41 ± 0.57 3.66 ± 0.82 0.199 Yes 17 (77.3%) 58 (65.9%)
PLT(× 109/L) 226 ± 137 278 ± 107 0.019 External ventricular drainage greater than 7 days(%) 0.151
Neutrophil percentage(%) 84 ± 8 77 ± 9 <0.001 No 9 (40.9%) 51 (58.0%)
Lymphocytes(× 109/L) 1.07 ± 0.56 1.31 ± 0.59 0.087 Yes 13 (59.1%) 37 (42.0%)
Monocytes(× 109/L) 0.76 ± 0.42 0.81 ± 0.53 0.994 CSF leakage(%) 0.684
Average platelet volume(fL) 11.41 ± 1.62 10.52 ± 1.09 0.02 No 21 (95.5%) 80 (90.9%)
Platelet mean width(fL) 15.19 ± 3.80 13.77 ± 11.10 0.005 Yes 1 (4.5%) 8 (9.1%)
Plateletcrit(%) 0.25 ± 0.13 0.29 ± 0.11 0.087 Extraspinal diversion(%) 0.049
Albumin (g/L) 33.2 ± 5.3 36.3 ± 4.8 0.002 No 18 (81.8%) 84 (95.5%)
Albumin to globulin ratio 1.48 ± 0.41 1.51 ± 0.36 0.403 Yes 4 (18.2%) 4 (4.5%)
CRP(mg/L) 79 ± 38 56 ± 47 0.003 V-P shunting(%) 0.755
Procalcitonin(ng/mL) 1.40 ± 1.83 0.32 ± 0.38 <0.001 No 18 (81.8%) 74 (84.1%)
D-D(mg/L) 4.1 ± 4.3 4.1 ± 4.1 0.799 Yes 4 (18.2%) 14 (15.9%)
PT(s) 14.19 ± 2.06 12.26 ± 1.31 <0.001 Diplopneumonia(%) 0.09
INR 1.69 ± 2.10 1.07 ± 0.12 <0.001 No 3 (13.6%) 28 (31.8%)
APTT(s) 38 ± 15 29 ± 7 0.003 Yes 19 (86.4%) 60 (68.2%)
Fibrinogen(g/L) 3.97 ± 1.54 4.00 ± 2.14 0.893 Deep vein cannulation(%) 0.017
Prothrombin time(s) 16.84 ± 2.28 16.30 ± 1.85 0.168 No 2 (9.1%) 31 (35.2%)
FDP(mg/L) 13 ± 12 13 ± 11 0.751 Yes 20 (90.9%) 57 (64.8%)
View table in article
表1 生存组与死亡组患者一般资料比较
本文的其它图/表